MarketCap
Facebook
X
Telegram
Spectrum Pharmaceuticals Current Ratio | SPPI
Annual Current Ratio Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.37 | 1.74 | 3.15 | 3.61 | 3.27 | 3.58 | 2.22 | 2.03 | 2.08 | 2.29 | 2.33 | 3.02 | 1.84 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.61 | 1.37 | 2.5 |
Quarterly Current Ratio Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.33 | 1.37 | 1.43 | 1.73 | 2.23 | 1.74 | 2.16 | 2.63 | 3.16 | 3.15 | 3.42 | 3.05 | 3.47 | 3.61 | 4.97 | 4.75 | 4.4 | 3.27 | 3.28 | 3.86 | 3.7 | 3.58 | 2.55 | 2.01 | 2.17 | 2.22 | 2.26 | 2.22 | 2.08 | 2.03 | 1.92 | 2.06 | 1.97 | 2.08 | 2.01 | 2.27 | 2.27 | 2.29 | 3 | 2.52 | 2.41 | 2.33 | 2.22 | 3.11 | 3.54 | 3.02 | 2.89 | 2.05 | 3.02 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.97 | 1.33 | 2.67 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Certara
CERT
|
3.15 | $ 12.21 | -0.08 % | $ 1.96 B |  USA |
 |
Dyadic International
DYAI
|
1.14 | $ 0.39 | 1.16 % | $ 14.1 M | USA |
 |
Intec Pharma Ltd
NTEC
|
2.81 | - | -12.45 % | $ 17.7 M |  Israel |
 |
Anika Therapeutics
ANIK
|
14.4 | $ 13.42 | -7.89 % | $ 192 M | USA |
 |
Aprea Therapeutics
APRE
|
9.42 | $ 0.45 | -9.44 % | $ 2.94 M | USA |
 |
Galectin Therapeutics
GALT
|
0.134 | $ 3.4 | -1.73 % | $ 217 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
4.43 | $ 73.22 | -2.41 % | $ 7.6 B | USA |
 |
Progenity, Inc.
PROG
|
1.74 | - | -3.47 % | $ 164 M | USA |
 |
Genprex
GNPX
|
4.62 | $ 2.1 | 1.94 % | $ 1.96 M | USA |
 |
Strongbridge Biopharma plc
SBBP
|
4.37 | - | 1.52 % | $ 136 M | USA |
 |
Innate Pharma S.A.
IPHA
|
2.03 | $ 1.54 | 1.98 % | $ 138 M |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
4.02 | - | -1.19 % | $ 28.7 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
5.04 | $ 57.1 | -0.14 % | $ 11 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
3.03 | $ 1.19 | -4.03 % | $ 6.51 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
1.3 | $ 11.24 | -2.01 % | $ 240 K | USA |
 |
SIGA Technologies
SIGA
|
10.6 | $ 3.14 | -3.83 % | $ 225 M | USA |
 |
Milestone Pharmaceuticals
MIST
|
1.58 | $ 0.68 | -7.49 % | $ 72.2 M |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
3.9 | $ 94.9 | -3.91 % | $ 7.04 B | USA |
 |
Lipocine
LPCN
|
6.73 | $ 1.59 | -7.85 % | $ 8.66 M | USA |
 |
PTC Therapeutics
PTCT
|
0.934 | $ 64.12 | -1.4 % | $ 5.1 B | USA |
 |
Seres Therapeutics
MCRB
|
1.47 | $ 1.55 | -8.75 % | $ 13.7 M | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
1.92 | $ 432.48 | -0.07 % | $ 9.7 B | USA |
 |
CEL-SCI Corporation
CVM
|
2.31 | $ 1.41 | 4.07 % | $ 11.3 M | USA |
 |
Inventiva S.A.
IVA
|
0.527 | $ 3.95 | 2.73 % | $ 236 M | France |
 |
MeiraGTx Holdings plc
MGTX
|
0.977 | $ 9.62 | 1.37 % | $ 774 M | USA |
 |
Processa Pharmaceuticals
PCSA
|
3.49 | $ 1.86 | -4.62 % | $ 2.44 M | USA |
 |
Eton Pharmaceuticals
ETON
|
1.4 | $ 67.5 | 4.9 % | $ 1.82 B | USA |
 |
IDEAYA Biosciences
IDYA
|
12.8 | $ 31.72 | -0.97 % | $ 2.81 B | USA |
 |
Protalix BioTherapeutics
PLX
|
2.41 | $ 2.86 | 11.28 % | $ 225 M | Israel |
 |
Lantern Pharma
LTRN
|
2.45 | $ 0.47 | -22.86 % | $ 5.12 M | USA |
 |
Foghorn Therapeutics
FHTX
|
0.646 | $ 1.89 | -7.35 % | $ 119 M | USA |
 |
Ocugen
OCGN
|
0.782 | $ 0.95 | -2.45 % | $ 297 M | USA |
 |
Oncolytics Biotech
ONCY
|
1.42 | $ 0.38 | -5.64 % | $ 36.4 M | Canada |
 |
Minerva Neurosciences
NERV
|
0.419 | $ 2.47 | -6.08 % | $ 20.9 M | USA |
 |
Kamada Ltd.
KMDA
|
6.58 | $ 8.09 | 4.93 % | $ 466 M | Israel |
 |
Neurocrine Biosciences
NBIX
|
3.36 | $ 169.08 | 0.13 % | $ 16.8 B | USA |
 |
Nanobiotix S.A.
NBTX
|
0.445 | $ 32.8 | 2.4 % | $ 1.57 T | France |
 |
Mereo BioPharma Group plc
MREO
|
3.36 | $ 0.3 | 1.66 % | $ 239 M |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
1.94 | $ 7.86 | -2.31 % | $ 1.13 B | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
2.39 | $ 1.84 | 0.82 % | $ 668 M | USA |
 |
Moleculin Biotech
MBRX
|
3.11 | $ 8.01 | -7.51 % | $ 9.49 M | USA |
 |
Nurix Therapeutics
NRIX
|
4.61 | $ 15.89 | -1.58 % | $ 1.38 B | USA |
 |
Nkarta
NKTX
|
4.4 | $ 1.36 | -14.78 % | $ 101 M | USA |
 |
MacroGenics
MGNX
|
1.28 | $ 2.42 | 3.42 % | $ 153 M | USA |
 |
Protagonist Therapeutics
PTGX
|
12.5 | $ 136.18 | 0.2 % | $ 8.66 B | USA |
|
Nuvation Bio
NUVB
|
2.06 | $ 4.22 | -3.1 % | $ 1.44 B | USA |
 |
Novo Nordisk A/S
NVO
|
1.56 | $ 40.6 | -1.88 % | $ 180 B |  Danmark |
 |
Marker Therapeutics
MRKR
|
8.39 | $ 0.95 | -3.87 % | $ 14.5 M | USA |
 |
NextCure
NXTC
|
2.16 | $ 5.97 | -4.78 % | $ 17 M | USA |
 |
Rocket Pharmaceuticals
RCKT
|
6.21 | $ 2.46 | -2.96 % | $ 273 M | USA |